Evidence map›Paper›PMID 42204803›Full record

ArticleCNS neuroscience & therapeutics2026

Biphasic Memory Impairment and Recovery After Sevoflurane Exposure Are Associated With Time-Dependent Hippocampal α5-GABAAR Remodeling.

Sixuan Wang, Lu Chen, Shengran Wang, Chen Zhang, Mengxue Zhang, Zhun Wang, Jinpeng Dong, Qiangwei Liu, Zhonglan Dong, Xiaokun Wang and 4 more

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sixuan WangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Lu ChenDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Shengran WangState Key Laboratory of National Security Specially Needed Medicines, Academy of Military Medical Sciences, Beijing, China.
Chen ZhangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Mengxue ZhangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zhun WangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Jinpeng DongDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Qiangwei LiuDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Zhonglan DongDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Xiaokun WangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Ying DongDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Yuan LuoState Key Laboratory of National Security Specially Needed Medicines, Academy of Military Medical Sciences, Beijing, China.
Yongan WangState Key Laboratory of National Security Specially Needed Medicines, Academy of Military Medical Sciences, Beijing, China.
Yiqing YinDepartment of Anesthesiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID 0009-0003-7969-8025

Funding

The Science & Technology Development Fund of Tianjin Education Commission for Higher Education 2022ZD063
6 · The paper itself

Abstract

backgroundDynamic modulation of α5-GABAAR expression and synaptic distribution plays a pivotal role in neuronal homeostatic plasticity, critically influencing memory processes. This study aims to investigate the spatiotemporal dynamics of α5-GABAAR in hippocampal subregions (CA1, CA3, and DG) and their behavioral correlation in mice following sevoflurane exposure across eight timepoints.

methodsEight-week-old female C57BL/6 mice were exposed to 3% sevoflurane for 1 h and they were subjected to trace fear conditioning followed by sevoflurane. Hippocampal tissues were harvested for proteomic analysis and immunofluorescence staining to quantify the expression of α5-GABAAR and P-gephyrin. Three-dimensional spatial colocalization of α5-GABAAR and gephyrin was reconstructed in IMARIS software.

resultsBy integrating trace fear conditioning with molecular profiling, we identified 2 days postexposure (Sev2d) as the critical phase for sevoflurane-induced memory impairment and 6 days postexposure (Sev6d) as the recovery phase. The time-dependent biphasic pattern of α5-GABAAR regulation was demonstrated by proteomics, immunofluorescence, and 3D imaging: (1) At Sev2d, α5-GABAAR expression and postsynaptic clustering were significantly elevated, which coincided with peak cognitive deficits; (2) by Sev6d, both receptor density and synaptic localization normalized to baseline level, paralleling memory restoration.

conclusionsThese findings indicate that changes in the expression and distribution of α5-GABAAR are correlated with sevoflurane-induced memory impairment and recovery, providing potential insights into sevoflurane-induced memory fluctuation.

Indexed as

Anesthetics, InhalationHippocampusMemory DisordersReceptors, GABA-ARecovery of FunctionSevofluraneAnimalsCarrier ProteinsFearFemaleMembrane ProteinsMiceMice, Inbred C57BLTime FactorsAnesthetics, InhalationCarrier ProteinsGabra5 protein, mousegephyrinMembrane ProteinsReceptors, GABA-ASevofluranegephyrinperioperative neurocognitive disordersevofluraneα5‐GABAAR

Identifiers

PMID42204803
PMCPMC13239462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.